Cargando…

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A(2) in human vulnerable atherosclerotic plaque

BACKGROUND: Atherosclerotic plaque vulnerability is a key feature of atheroprogression and precipitating acute cardiovascular events. Although the pivotal role of epigenetic regulation in atherosclerotic plaque destabilization is being recognized, the DNA methylation profile and its potential role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jingjin, Zhang, Xiaoping, Yang, Mengxi, Yang, Hang, Xu, Ning, Fan, Xueqiang, Liu, Gang, Jiang, Xintong, Fan, Jiasai, Zhang, Lifang, Zhang, Hu, Zhou, Ying, Li, Rui, Gao, Si, Jin, Jiangli, Jin, Zening, Zheng, Jingang, Tu, Qiang, Ren, Jingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379831/ https://www.ncbi.nlm.nih.gov/pubmed/34419168 http://dx.doi.org/10.1186/s13148-021-01152-z

Ejemplares similares

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice
por: Wang, Wen-yi, et al.
Publicado: (2011)

Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A(2)
por: Fenning, Robert S., et al.
Publicado: (2015)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A(2) and carboxyl ester lipase lipases in atherosclerotic plaque formation
por: Burchardt, Paweł, et al.
Publicado: (2013)

Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study
por: Gao, Weibo, et al.
Publicado: (2021)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Analysis of MicroRNAs Associated With Carotid Atherosclerotic Plaque Rupture With Thrombosis
por: Nie, Peng, et al.
Publicado: (2021)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

Identification of immune infiltration-related biomarkers in carotid atherosclerotic plaques
por: Zheng, Kai, et al.
Publicado: (2023)

Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
por: Chalmers, Alexander D., et al.
Publicado: (2017)

Lipoprotein-Associated Phospholipase A(2) Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome
por: Chung, Hyemoon, et al.
Publicado: (2014)

MiR-4291 stabilized the vulnerable atherosclerotic plaques by degrading the MAPK1/ERK2 in ApoE(-/-) mice
por: Jin, Yaqiong, et al.
Publicado: (2022)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Characterization of atherosclerotic carotid plaque using MATCH: initial clinical experience
por: Yu, Wei, et al.
Publicado: (2015)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy
por: Zhang, Mengyuan, et al.
Publicado: (2017)

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
por: Zhou, Boda, et al.
Publicado: (2017)

Association Between Plasma Lipoprotein-Associated Phospholipase A2 and Plaque Vulnerability in TIA Patients With Unilateral Middle Cerebral Artery Stenosis
por: Qin, Yiren, et al.
Publicado: (2020)

Diagnostic Predictive Value of Tryptase, Serum Amyloid A and Lipoprotein-Associated Phospholipase A2 Biomarker Groups for Large Atherosclerotic Cerebral Infarction
por: Jia, Wenhui, et al.
Publicado: (2022)

Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
por: McGarrah, Robert W., et al.
Publicado: (2022)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
por: Gao, Wen-Qian, et al.
Publicado: (2014)

Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages
por: XU, RUIJIN, et al.
Publicado: (2015)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Correlation between aortic/carotid atherosclerotic plaques and cerebral infarction
por: WANG, BAOJUN, et al.
Publicado: (2013)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Analysis of atherosclerotic plaque distribution in the carotid artery
por: Yang, Shin‐Seok, et al.
Publicado: (2022)

Desipramine enhances the stability of atherosclerotic plaque in rabbits monitored with molecular imaging
por: Zhao, Min, et al.
Publicado: (2023)

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
por: Zhang, Ming, et al.
Publicado: (2022)

Role of Pyroptosis and Ferroptosis in the Progression of Atherosclerotic Plaques
por: Yang, Zhen, et al.
Publicado: (2022)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease
por: Niccoli, Giampaolo, et al.
Publicado: (2016)

Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity
por: Jiang, Xintong, et al.
Publicado: (2019)

Effects of withdrawing an atherogenic diet on the atherosclerotic plaque in rabbits
por: Zhao, Lijun, et al.
Publicado: (2021)

Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms
por: Tian, Yuling, et al.
Publicado: (2017)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques
por: Li, Yuxin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0v82qc8q9foql97geeldkis2ts